首页> 外文期刊>Journal of Molecular Medicine >Effects of PGI2 analogues on Th1- and Th2-related chemokines in monocytes via epigenetic regulation
【24h】

Effects of PGI2 analogues on Th1- and Th2-related chemokines in monocytes via epigenetic regulation

机译:PGI 2 类似物通过表观遗传调控对单核细胞Th1和Th2相关趋化因子的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Chemokines play important roles in asthma. Prostaglandin I2 (PGI2) analogue is recently suggested as a candidate for treating asthma. However, the effects of PGI2 analogues on the expression of Th1- and Th2-related chemokines are unknown. To this end, we investigated the in vitro effects of PGI2 analogues on the expression of Th1-related chemokine interferon-γ-inducible protein-10 (IP-10/CXCL10) and Th2-related chemokine macrophage-derived chemokine (MDC/CCL22) in human monocytes. The human monocytes were pretreated with iloprost and treprostinil before lipopolysaccharide (LPS) stimulation. IP-10 and MDC were measured by ELISA. Intracellular signaling was investigated by cyclic adenosine monophosphate (cAMP) assay, western blot and chromatin immunoprecipitation. PGI2 analogues enhanced MDC, but suppressed IP-10 expression in LPS-stimulated monocytes. These effects were reversed by the I prostanoid (IP) receptor antagonist (CAY10449), peroxisomal proliferators-activated receptor (PPAR)-α antagonist (GW6741) and PPAR-γ antagonist (GW9662). PGI2 analogues increased intracellular cAMP levels. Forskolin, an adenyl cyclase activator, conferred similar effects. PGI2 analogue-enhanced MDC expression was reduced by nuclear factor (NF) κB inhibitor (BAY 117085) and mitogen-activated protein kinase (MAPK)-p38 inhibitor (SB203580). PGI2 analogues up-regulated phospho-p65 and phospho-p38 but down-regulated phospho-ERK expression. Iloprost enhanced H3 acetylation in MDC promoter area and suppressed H3 acetylation, H3K4, and H3K36 trimethylation in IP-10 promoter area. PGI2 analogues enhanced MDC expression via the I prostanoid-receptor-cAMP, PPAR-α and PPAR-γ, NFκB-p65, MAPK-p38-ATF2 pathways and increasing histone acetylation, and suppressed IP-10 expression via the IP-receptor-cAMP, PPAR-γ, MAPK-ERK-ELK1 pathways and inhibiting histone acetylation and trimethylation in LPS-stimulated monocytes. PGI2 analogues may therefore increase Th2 recruitment and inflammation.
机译:趋化因子在哮喘中起重要作用。最近有人建议使用前列腺素I 2 (PGI 2 )类似物作为治疗哮喘的候选药物。然而,PGI 2 类似物对Th1和Th2相关趋化因子表达的影响尚不清楚。为此,我们研究了PGI 2 类似物对Th1相关趋化因子干扰素-γ诱导蛋白10(IP-10 / CXCL10)和Th2相关趋化因子巨噬细胞表达的体外影响。人单核细胞中衍生的趋化因子(MDC / CCL22)。在脂多糖(LPS)刺激之前,用伊洛前列素和曲前列环素预处理人单核细胞。通过ELISA测量IP-10和MDC。通过环磷酸一腺苷(cAMP)分析,蛋白质印迹和染色质免疫沉淀研究了细胞内信号传导。 PGI 2 类似物增强MDC,但抑制LPS刺激的单核细胞IP-10表达。这些作用被I类前列腺素(IP)受体拮抗剂(CAY10449),过氧化物酶体增殖物激活受体(PPAR)-α拮抗剂(GW6741)和PPAR-γ拮抗剂(GW9662)所逆转。 PGI 2 类似物增加细胞内cAMP水平。 Forskolin是一种腺苷酸环化酶激活剂,具有类似的作用。 PGI 2 类似物增强的MDC表达被核因子(NF)κB抑制剂(BAY 117085)和促分裂原活化蛋白激酶(MAPK)-p38抑制剂(SB203580)降低。 PGI 2 类似物上调磷酸化p65和磷酸化p38,但下调磷酸化ERK表达。伊洛前列素增强了MDC启动子区域的H3乙酰化,并抑制了IP-10启动子区域的H3乙酰化,H3K4和H3K36三甲基化。 PGI 2 类似物通过I类前列腺素受体cAMP,PPAR-α和PPAR-γ,NFκB-p65,MAPK-p38-ATF2途径增强MDC表达并增加组蛋白乙酰化,并抑制IP-10通过IP受体cAMP,PPAR-γ,MAPK-ERK-ELK1途径表达,并抑制LPS刺激的单核细胞中的组蛋白乙酰化和三甲基化。因此,PGI 2 类似物可能会增加Th2的募集和炎症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号